Hyperlipidemia in HIV-infected patients: the protective effect of hepatitis C virus co-infection

被引：21

作者：

Collazos, J ^{[1
]}

Mayo, J ^{[1
]}

Ibarra, S ^{[1
]}

Cazallas, J ^{[1
]}

机构：

[1] Hosp Galdakao, Infect Dis Sect, Vizcaya, Spain

来源：

AIDS | 2003年 / 17卷 / 06期

关键词：

D O I：

10.1097/00002030-200304110-00023

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The prevalence of hyperlipidemia and factors related to it have been studied in a large sample of patients. We found a significant association between hyperlipidemia and the duration of antiretroviral therapy, serum cortisol levels, the presence of lipodystrophy, certain antiretroviral regimens and, especially, the absence of hepatitis C virus (HCV) infection. Patients co-infected with HCV,had considerably lower rates of hyperlipidemia than non-infected patients, and this effect was particularly evident in patients treated with antiretroviral drugs.

引用

收藏

页码：927 / 929

页数：3

相关论文

共 11 条

[1] Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].

Behrens, G ;

Dejam, A ;

Schmidt, H ;

Balks, HJ ;

Brabant, G ;

Körner, T ;

Stoll, M ;

Schmidt, RE .

AIDS, 1999, 13 (10) :F63-F70

[2] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].

Carr, A ;

Samaras, K ;

Thorisdottir, A ;

Kaufmann, GR ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1999, 353 (9170) :2093-2099

[3] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[4] Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis [J].

Cicognani, C ;

Malavolti, M ;

MorselliLabate, AM ;

Zamboni, L ;

Sama, C ;

Barbara, L .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (07) :792-796

[5]

Duong M, 2001, J ACQ IMMUN DEF SYND, V27, P245, DOI 10.1097/00126334-200107010-00005

[6] Blood lipids of patients with chronic hepatitis: Differences related to viral etiology [J].

Fabris, C ;

Federico, E ;

Soardo, G ;

Falleti, E ;

Pirisi, M .

CLINICA CHIMICA ACTA, 1997, 261 (02) :159-165

[7] Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy [J].

Gervasoni, C ;

Ridolfo, AL ;

Trifirò, G ;

Santambrogio, S ;

Norbiato, G ;

Musicco, M ;

Clerici, M ;

Galli, M ;

Moroni, M .

AIDS, 1999, 13 (04) :465-471

[8] Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy [J].

Hadigan, C ;

Meigs, JB ;

Corcoran, C ;

Rietschel, P ;

Piecuch, S ;

Basgoz, N ;

Davis, B ;

Sax, P ;

Stanley, T ;

Wilson, PWF ;

D'Agostino, RB ;

Grinspoon, S .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :130-139

[9] Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine [J].

Martínez, E ;

Conget, I ;

Lozano, L ;

Casamitjana, R ;

Gatell, JM .

AIDS, 1999, 13 (07) :805-810

[10] Fat distribution and metabolic changes in patients with HIV infection [J].

Safrin, S ;

Grunfeld, C .

AIDS, 1999, 13 (18) :2493-2505